{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,8]],"date-time":"2026-11-08T04:07:40Z","timestamp":1794110860731,"version":"4.8.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Immunology"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.humimm.2023.02.002","type":"journal-article","created":{"date-parts":[[2023,2,13]],"date-time":"2023-02-13T00:21:32Z","timestamp":1676247692000},"page":"263-271","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["HLA-E*01:01\u00a0+\u00a0HLA-E*01:01 genotype confers less susceptibility to COVID-19, while HLA-E*01:03\u00a0+\u00a0HLA-E*01:03 genotype is associated with more severe disease"],"prefix":"10.1016","volume":"84","author":[{"given":"Ehteramolsadat","family":"Hosseini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arefeh","family":"Minagar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1128-5649","authenticated-orcid":false,"given":"Mehran","family":"Ghasemzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Arabkhazaeli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0312-7643","authenticated-orcid":false,"given":"Alireza","family":"Ghasemzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.humimm.2023.02.002_b0005","doi-asserted-by":"crossref","unstructured":"Acter T, Uddin N, Das J, Akhter A, Choudhury TR, Kim S: Evolution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) as coronavirus disease 2019 (COVID-19) pandemic: A global health emergency. Science of the Total Environment 2020:138996.","DOI":"10.1016\/j.scitotenv.2020.138996"},{"key":"10.1016\/j.humimm.2023.02.002_b0010","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.coviro.2011.10.017","article-title":"Natural killer cell responses during viral infections: flexibility and conditioning of innate immunity by experience","volume":"1","author":"Vidal","year":"2011","journal-title":"Current opinion in virology"},{"key":"10.1016\/j.humimm.2023.02.002_b0015","doi-asserted-by":"crossref","DOI":"10.1002\/art.41285","article-title":"On the alert for cytokine storm: Immunopathology in COVID-19","author":"Henderson","year":"2020","journal-title":"Arthritis & Rheumatology"},{"key":"10.1016\/j.humimm.2023.02.002_b0020","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.coi.2016.11.003","article-title":"NK cells in host responses to viral infections","volume":"44","author":"Lam","year":"2017","journal-title":"Current opinion in immunology"},{"key":"10.1016\/j.humimm.2023.02.002_b0025","doi-asserted-by":"crossref","first-page":"7639","DOI":"10.18632\/aging.103101","article-title":"Immune environment modulation in pneumonia patients caused by coronavirus: SARS-CoV, MERS-CoV and SARS-CoV-2","volume":"12","author":"Yao","year":"2020","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.humimm.2023.02.002_b0030","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.leukres.2015.12.002","article-title":"NK cell maturation to CD56dim subset associated with high levels of NCRs overrides the inhibitory effect of NKG2A and recovers impaired NK cell cytolytic potential after allogeneic hematopoietic stem cell transplantation","volume":"43","author":"Ghasemzadeh","year":"2016","journal-title":"Leukemia research"},{"key":"10.1016\/j.humimm.2023.02.002_b0035","doi-asserted-by":"crossref","first-page":"4135","DOI":"10.1182\/blood-2004-10-4113","article-title":"NK-cell reconstitution after haploidentical hematopoietic stem-cell transplantations: immaturity of NK cells and inhibitory effect of NKG2A override GvL effect","volume":"105","author":"Nguyen","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.humimm.2023.02.002_b0040","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1016\/j.cell.2018.10.014","article-title":"Anti-NKG2A mAb is a checkpoint inhibitor that promotes anti-tumor immunity by unleashing both T and NK cells","volume":"175","author":"Andr\u00e9","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.humimm.2023.02.002_b0045","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/ni757","article-title":"CD94-NKG2A receptors regulate antiviral CD8+ T cell responses","volume":"3","author":"Moser","year":"2002","journal-title":"Nature immunology"},{"key":"10.1016\/j.humimm.2023.02.002_b0050","doi-asserted-by":"crossref","first-page":"5199","DOI":"10.1073\/pnas.95.9.5199","article-title":"HLA-E is a major ligand for the natural killer inhibitory receptor CD94\/NKG2A","volume":"95","author":"Lee","year":"1998","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"10.1016\/j.humimm.2023.02.002_b0055","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1002\/(SICI)1521-4141(199902)29:02<537::AID-IMMU537>3.0.CO;2-6","article-title":"Cell surface expression of HLA-E: interaction with human \u03b22-microglobulin and allelic differences","volume":"29","author":"Ulbrecht","year":"1999","journal-title":"European journal of immunology"},{"key":"10.1016\/j.humimm.2023.02.002_b0060","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.exphem.2014.11.007","article-title":"Do human leukocyte antigen E polymorphisms influence graft-versus-leukemia after allogeneic hematopoietic stem cell transplantation?","volume":"43","author":"Hosseini","year":"2015","journal-title":"Experimental hematology"},{"key":"10.1016\/j.humimm.2023.02.002_b0065","article-title":"Innate immunity in COVID-19 patients mediated by NKG2A receptors, and potential treatment using Monalizumab, Cholroquine, and antiviral agents","volume":"109777","author":"Yaqinuddin","year":"2020","journal-title":"Medical Hypotheses"},{"key":"10.1016\/j.humimm.2023.02.002_b0070","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1177\/135965350501000107","article-title":"HIV-1 infection leads to increased HLA-E expression resulting in impaired function of natural killer cells","volume":"10","author":"Nattermann","year":"2005","journal-title":"Antivir Ther"},{"key":"10.1016\/j.humimm.2023.02.002_b0075","doi-asserted-by":"crossref","unstructured":"Maucourant C, Filipovic I, Ponzetta A, Aleman S, Cornillet M, Hertwig Let al. : Natural killer cell immunotypes related to COVID-19 disease severity. Science immunology 2020;5:eabd6832.","DOI":"10.1126\/sciimmunol.abd6832"},{"key":"10.1016\/j.humimm.2023.02.002_b0080","article-title":"Exhausted NK cells and cytokine storms in COVID-19: Whether NK cell therapy could be a therapeutic choice","author":"Ghasemzadeh","year":"2021","journal-title":"Human immunology"},{"key":"10.1016\/j.humimm.2023.02.002_b0085","doi-asserted-by":"crossref","first-page":"75","DOI":"10.4103\/0974-777X.182121","article-title":"Human leukocyte antigen-e alleles are associated with hepatitis c virus, torque teno virus, and toxoplasma co-infections but are not associated with hepatitis b virus, hepatitis d virus, and GB virus c co-infections in human immunodeficiency virus patients","volume":"8","author":"Prasetyo","year":"2016","journal-title":"Journal of Global Infectious Diseases"},{"key":"10.1016\/j.humimm.2023.02.002_b0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.humimm.2022.04.010","article-title":"HLA-E* 01: 01 allele is associated with better response to anti-HCV therapy while homozygous status for HLA-E* 01: 03 allele increases the resistance to anti-HCV treatments in frequently transfused thalassemia patients","author":"Hosseini","year":"2022","journal-title":"Hum Immunol"},{"key":"10.1016\/j.humimm.2023.02.002_b0095","doi-asserted-by":"crossref","first-page":"5496","DOI":"10.3390\/ijms20215496","article-title":"Dimorphism of HLA-E and its Disease Association","volume":"20","author":"Kanevskiy","year":"2019","journal-title":"International journal of molecular sciences"},{"key":"10.1016\/j.humimm.2023.02.002_b0100","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1155\/2010\/907092","article-title":"The Emerging Role of HLA-E-Restricted CD8+ T Lymphocytes in the Adaptive Immune Response to Pathogens and Tumors","volume":"2010","author":"Pietra","year":"2010","journal-title":"Journal of Biomedicine and Biotechnology"},{"key":"10.1016\/j.humimm.2023.02.002_b0105","article-title":"The demographic and serological characteristics of COVID-19 convalescent plasma donors: Identification of basic criteria for optimal donor selection","volume":"103302","author":"Fazeli","year":"2021","journal-title":"Transfusion and Apheresis Science"},{"key":"10.1016\/j.humimm.2023.02.002_b0110","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.tracli.2021.08.008","article-title":"Positive anti-SARS-CoV-2 rapid serological test results among asymptomatic blood donors","volume":"29","author":"Arabkhazaeli","year":"2022","journal-title":"Transfusion Clinique et Biologique"},{"key":"10.1016\/j.humimm.2023.02.002_b0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-020-19481-7","article-title":"Low SARS-CoV-2 seroprevalence in blood donors in the early COVID-19 epidemic in the Netherlands","volume":"11","author":"Slot","year":"2020","journal-title":"Nature communications"},{"key":"10.1016\/j.humimm.2023.02.002_b0120","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.tmrv.2021.10.007","article-title":"Tracking SARS-CoV-2 seroprevalence among Canadian blood donors","volume":"36","author":"Saeed","year":"2022","journal-title":"Transfusion medicine reviews"},{"key":"10.1016\/j.humimm.2023.02.002_b0125","article-title":"Seroprevalence of SARS-CoV-2 antibodies among healthy blood donors in Karachi","volume":"59","author":"Younas","year":"2020","journal-title":"Pakistan. Transfusion and Apheresis Science"},{"key":"10.1016\/j.humimm.2023.02.002_b0130","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.humimm.2021.01.018","article-title":"HLA-E gene polymorphisms in chronic hepatitis C: Impact on HLA-E liver expression and disease severity","volume":"82","author":"Ara\u00fajo","year":"2021","journal-title":"Human immunology"},{"key":"10.1016\/j.humimm.2023.02.002_b0135","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1086\/605889","article-title":"The HLA-ER\/HLA-ER Genotype Affects the Natural Course of Hepatitis C Virus (HCV) Infection and Is Associated with HLA-E\u2013Restricted Recognition of an HCV-Derived Peptide by Interferon-\u03b3\u2013Secreting Human CD8+ T Cells","volume":"200","author":"Schulte","year":"2009","journal-title":"The Journal of infectious diseases"},{"key":"10.1016\/j.humimm.2023.02.002_b0140","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1097\/QAD.0b013e32835f5b9c","article-title":"HLA-E variants are associated with sustained virological response in HIV\/hepatitis C virus-coinfected patients on hepatitis C virus therapy","volume":"27","author":"Guzm\u00e1n-Fulgencio","year":"2013","journal-title":"AIDS"},{"key":"10.1016\/j.humimm.2023.02.002_b0145","doi-asserted-by":"crossref","first-page":"10896","DOI":"10.1073\/pnas.1834449100","article-title":"HLA-E-restricted recognition of cytomegalovirus-derived peptides by human CD8+ cytolytic T lymphocytes","volume":"100","author":"Pietra","year":"2003","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"10.1016\/j.humimm.2023.02.002_b0150","doi-asserted-by":"crossref","DOI":"10.1155\/2010\/907092","article-title":"The emerging role of HLA-E-restricted CD8+ T lymphocytes in the adaptive immune response to pathogens and tumors","volume":"2010","author":"Pietra","year":"2010","journal-title":"Journal of Biomedicine and Biotechnology"},{"key":"10.1016\/j.humimm.2023.02.002_b0155","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1126\/science.aay7079","article-title":"Mobilizing unconventional T cells","volume":"366","author":"Ottenhoff","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.humimm.2023.02.002_b0160","doi-asserted-by":"crossref","first-page":"e185","DOI":"10.1111\/bjh.16895","article-title":"Harnessing HLA-E-restricted CD8 T lymphocytes for adoptive cell therapy of patients with severe COVID-19","volume":"190","author":"Caccamo","year":"2020","journal-title":"British journal of haematology"},{"key":"10.1016\/j.humimm.2023.02.002_b0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.110503","article-title":"SARS-CoV-2 Nsp13 encodes for an HLA-E-stabilizing peptide that abrogates inhibition of NKG2A-expressing NK cells","volume":"38","author":"Hammer","year":"2022","journal-title":"Cell reports"},{"key":"10.1016\/j.humimm.2023.02.002_b0170","doi-asserted-by":"crossref","unstructured":"Strong RK, Holmes MA, Li P, Braun L, Lee N, Geraghty DE: HLA-E allelic variants. Correlating differential expression, peptide affinities, crystal structures, and thermal stabilities. J Biol Chem 2003;278:5082.","DOI":"10.1074\/jbc.M208268200"},{"key":"10.1016\/j.humimm.2023.02.002_b0175","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/S0198-8859(00)00190-7","article-title":"Implications of HLA-E allele expression and different HLA-E ligand diversity for the regulation of NK cells","volume":"61","author":"Maier","year":"2000","journal-title":"Hum Immunol"}],"container-title":["Human Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885923000289?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885923000289?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T11:57:56Z","timestamp":1759319876000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0198885923000289"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":35,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["S0198885923000289"],"URL":"https:\/\/doi.org\/10.1016\/j.humimm.2023.02.002","relation":{},"ISSN":["0198-8859"],"issn-type":[{"value":"0198-8859","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"HLA-E*01:01\u00a0+\u00a0HLA-E*01:01 genotype confers less susceptibility to COVID-19, while HLA-E*01:03\u00a0+\u00a0HLA-E*01:03 genotype is associated with more severe disease","name":"articletitle","label":"Article Title"},{"value":"Human Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humimm.2023.02.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}